Involvement of ceramide and JNK in CD40-mediated growth inhibition.
Armour
C A
CA
Institute for Cancer Studies, University of Birmingham, Edgbaston, U.K.
Eliopoulos
A G
AG
Dawson
C W
CW
Young
L S
LS
Wakelam
M J
MJ
D019943:Amino Acid Substitution; D000818:Animals; D019013:CD40 Antigens / Q000096:biosynthesis / Q000502:physiology*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism*; D002455:Cell Division / Q000502:physiology*; D002460:Cell Line; D002518:Ceramides / Q000096:biosynthesis / Q000502:physiology*; D004351:Drug Resistance; D005347:Fibroblasts; D005839:Gentamicins / Q000633:toxicity; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases; D016297:Mutagenesis, Site-Directed; D051381:Rats; D011994:Recombinant Proteins / Q000096:biosynthesis; D014162:Transfection; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms
D019013:CD40 Antigens; D002518:Ceramides; D005839:Gentamicins; D011994:Recombinant Proteins; C010680:antibiotic G 418; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases